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40 years [4], respectively). Because 
IgG against LCMV can persist for 
years, seroprevalence would be 
expected to be higher for an older 
population as a result of more chances 
for exposure. Also, a serosurvey of 
>1,000 hospitalized persons from 
upstate New York in the 1970s 
detected no positive antibody titers 
(6), consistent with our ﬁ  ndings.
Our serosurvey had a few 
limitations. Blood samples from an 
entire county cannot detect potential 
household- or neighborhood-scale 
areas of increased risk for LCMV 
exposure, which may be related to focal 
distribution of populations of LCMV-
infected house mice. Serosurveys of 
house mice have previously shown 
evidence for clustering of LCMV-
infected individuals (7); however, the 
prevalence of LCMV in house mice 
in Onondaga County is unknown. 
Additionally, because blood donors 
were volunteers, the population 
sampled did not necessarily reﬂ  ect the 
population at risk for LCMV exposure. 
Despite these considerations, the 
low prevalence of LCMV antibodies 
suggests low occurrence of LCMV 
exposure in this population.
Although little is known about 
frequency of human exposure and 
infection, LCMV seems to be rare 
with a propensity for inducing severe 
disease. LCMV infection has been 
associated with high incidence of 
clinical disease, including a pet 
hamster–associated outbreak in 1973–
1974 that resulted in at least 181 cases 
and 46 hospitalizations in 12 states (8).
LCMV-related disease is 
reportable in only 3 states (Wisconsin, 
Massachusetts, Arizona) and 1 
city (New York, New York) and is 
considered to be widely undertested 
and underdiagnosed. A recent 
survey of health care providers 
in Connecticut found that LCMV 
diagnostic tests were not requested for 
all patients suspected to have LCMV 
infection (9); thus, missed diagnoses 
are possible. Additional studies are 
needed to understand the incidence 
of LCMV-related disease and 
LCMV seroprevalence in the general 
population (10).
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Tickborne 
Relapsing Fever 
Caused by Borrelia 
persica, Uzbekistan 
and Tajikistan
To the Editor: Tickborne 
relapsing fever (TBRF) is caused 
by several Borrelia species and 
transmitted by argasid soft ticks of the 
genus  Ornithodoros. The disease is 
endemic to many parts of the world, 
especially Africa (B. duttonii and B. 
crocidurae  most prevalent), and the 
Mediterranean basin (B. hispanica 
most prevalent). In Eurasia, TBRF is 
mainly caused by B. persica ( 1–3). 
We report a patient who returned to 
France with B. persica infection after 
visiting Uzbekistan and Tajikistan.
In September 2008, a 32-year-old 
man sought care at the Saint Louis 
Hospital in Paris, France, for a ﬁ  fth 
relapsing episode of fever. Three 
weeks earlier (July 31–August 18), 
he had trekked through Uzbekistan 
and Tajikistan and spent 7 nights in 
a tent in Uzbekistan. The day before 
his return to France, he had fever 
(39.5°C) that lasted 5 days without 
other symptoms. After a 4-day 
interval, fever recurred for 1 day, then 
relapsed 3 other times (every 2 days 
with fever for 12 hours). Laboratory 
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investigations performed earlier by 
his general physician on August 19 
and 20 showed lymphopenia (0.76 
× 109 cells/L and 0.44 × 109 cells/L), 
thrombocytopenia (94 ×109 cells/L 
and 80 ×109 cells/L), and C-reactive 
protein level 300 mg/L (reference 
level <6 mg/L).
Physical examination when the 
man was afebrile found no clinical 
abnormalities. He did not recall tick 
bites, and no lesion was seen on his 
skin. Laboratory investigations on 
September 2 indicated persistant 
lymphopenia (1.0 × 109 cells/L), C-
reactive protein 96 mg/L, and mild 
cholestasis (alkaline phosphatase 
level 125 UI/L and gamma glutamyl 
transferase level 92 UI/L). Thick and 
thin Giemsa-stained blood smears 
showed neither Plasmodium spp. nor 
Borrelia spp. However, quantitative 
buffy coat analysis (QBC; Becton 
Dickinson, Le Pont de Claix, France) 
showed numerous spirochetes, which 
prompted a rereview and careful 
analysis of the slides, during which 
spirochetes were infrequently seen. 
PCR and sequencing of the 16S 
rRNA gene, performed as previously 
described, from a whole blood sample 
identiﬁ  ed these bacteria as B. persica 
(1).
According to current 
recommendations in France, the 
patient was given doxycycline, 200 
mg/d, for 10 days. During the ﬁ  rst 
12 hours, he was monitored for a 
Jarish–Herxheimer reaction, which 
was not observed. By the end of 
therapy, inﬂ  ammatory syndrome and 
lymphopenia had resolved.
Despite high-level sequence 
conservation, identiﬁ  cation of Borrelia 
spp. by sequencing the 16S rRNA 
gene is reliable and useful for clinical 
practice (1,4–6). The sequence obtained 
from the patient reported here was 
identical (100% identity over 1,472 bp) 
to the B. persica HM161645 reference 
sequence available from GenBank 
and sampled from the Galilee region 
of Israel. It differed by 2 nt (99.86% 
identity) from B. persica U42297 
and another unpublished sequence 
(B. persica 11/95), each from Iran. 
B. persica 11/95 was obtained from 
blood from a rodent collected in Iran 
and examined at the Institut Pasteur 
of Iran. We submitted the 2 B. persica 
sequences (1 from the patient reported 
here and 1 from the 11/95 sample) to 
GenBank (accession nos. HQ610930 
and HQ610931, respectively). We 
conﬁ  rmed identiﬁ  cation of B. persica 
from the patient reported here by 
sequencing of both ﬂ  aB and intergenic 
spacer domains (data not shown), as 
described (7,8).
Although recently reviewed, 
the epidemiology of TBRF in the 
area of the former Union of Soviet 
Socialist Republics has not been 
extensively described (3). In most 
of these countries, the infection is 
mainly attributed to B. persica and 
transmitted by Ornithodoros tholozani 
ticks, which live in caves, soil, wall 
crevices, houses, and cow sheds. 
Mammalian reservoirs, if any, are not 
known (3). However, other agents have 
been reported, such as B. latyschewii 
(transmitted  by O. tartakovskyi 
ticks, which inhabit rodent burrows) 
in Kazakhstan, Uzbekistan, and 
Turkmenistan and B. caucasica 
(transmitted by O. verrucosus ticks) in 
the western shore of the Caspian Sea 
(Armenia, Azerbaijan, and Georgia) 
(9,10). Other soft ticks (O. nereensis 
and  O. alactagalis) have been 
described in central Asia.
To our knowledge, TBRF cases 
caused by B. persica in Uzbekistan 
and Tajikistan have been rarely 
reported. The clinical illness of the 
patient reported here did not differ 
substantially from that of patients 
in Israel, Iran, or Jordan, where the 
infection is more frequently detected. 
The illness appears benign without 
chills, headache, vomiting, arthralgia, 
epistaxis, or hematuria. However, 
lymphopenia, which resolved rapidly, 
has not been described for other TBRF 
cases.
Our report highlights that TBRF 
is endemic to countries of the former 
Union of Soviet Socialist Republics. 
Physicians should consider this 
diagnosis for febrile patient returning 
from this area. Efforts to prevent 
tick bites should be emphasized. 
Accurate microbiological diagnosis 
comprises molecular detection or 
quantitative buffy coat analyses, 
each of which enhances sensitivity. 
However, in most disease-endemic 
countries, diagnosis is based only on 
examination of direct blood smears, 
which can lead to false-negative 
results and underestimation of the 
actual extent of this infection (1).
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Toxoplasmosis and 
Horse Meat, France
To the Editor:  Toxoplasma 
gondii parasites are obligate 
intracellular apicomplexans that can 
infect virtually all warm-blooded 
animals; felids are deﬁ  nitive  hosts. 
The most common sources of human 
infection are ingestion of tissue cysts 
in undercooked meat or of food or 
water contaminated with oocysts 
shed by felids and transplacental 
transmission. Acquired toxoplasmosis 
in immunocompetent humans is 
frequently asymptomatic but is 
associated with cervical or occipital 
lymphadenopathy in ≈10% of 
patients. Severe or fatal outcomes for 
immunocompetent patients have been 
attributed to the virulence of speciﬁ  c 
T. gondii genotypes (1). We describe 
3 cases of toxoplasmosis caused by 
atypical strains probably acquired 
by from ingestion of raw horse meat 
imported from Canada and Brazil.
Patient 1, a 74-year-old man, was 
hospitalized locally (Antibes-Juan 
Les Pins, southern France) in March 
2009 for asthenia and persistent 
febrile bronchitis. His medical history 
included severe smoking-related 
chronic obstructive pulmonary disease 
and coronary artery disease. He 
received broad-spectrum antimicrobial 
drugs and methylprednisolone. 
On day 23 after admission, he was 
transferred to our teaching hospital in 
Nice because of clinical deterioration 
and persistent fever. Disseminated 
toxoplasmosis was diagnosed on the 
basis of serologic evidence of recent 
primary  T. gondii parasite infection 
and quantitative PCR detection of high 
Toxoplasma DNA levels in peripheral 
blood. Despite speciﬁ  c antitoxoplasma 
therapy with sulfadiazine and 
pyrimethamine, he remained febrile, 
his respiratory function worsened, and 
he died on day 27.
Patient 2, a 24-year-old 
pregnant woman, was hospitalized 
in Draguignan, France, in December 
2009 for full-term delivery. Three 
weeks earlier, routine serologic testing 
showed  T. gondii parasite infection 
seroconversion. The newborn’s and 
mother’s ophthalmologic examinations 
were unremarkable. Congenital 
toxoplasmosis was diagnosed on the 
basis immunoglobulin M in the infant’s 
serum, positive quantitative PCR of 
samples from the placenta, and strain 
isolation after inoculation of mice with 
a placental preparation. Sulfadiazine 
and pyrimethamine were started.
We performed a retrospective 
epidemiologic investigation of an 
unusual case of toxoplasmosis that 
occurred in March 1991. Patient 3, a 
21-year-old pregnant woman living 
in the Nice area, was treated with 
spiramycine because routine serologic 
testing had shown T. gondii parasite 
infection seroconversion at 22 weeks’ 
gestation. Amniocentesis showed 
T. gondii tachyzoites in amniotic 
ﬂ   uid by microscopic examination. 
At 26 weeks’ gestation, the woman 
underwent termination of pregnancy 
for ultrasonography-detected fetal 
severe abnormalities. Fetal necropsy 
showed numerous cerebral, cardiac, 
and hepatic abscesses with T. gondii 
tachyzoites. A few days after pregnancy 
termination, the woman experienced 
cervical lymphadenopathy, which 
lasted 3 years. She reported having 
eaten raw horse meat regularly during 
her pregnancy.
Genetic analyses with 
microsatellite markers of the 
Toxoplasma spp. strains isolated 
from the 3 patients found 3 different 
atypical genotypes. Atypical strains 
are common in South America but 
unusual in France, where >95% 
of reported strains collected from 
human and animal toxoplasmosis 
cases belonged to the type II clonal 
lineage (2,3). Hence, isolation of an 
atypical  Toxoplasma genotype from 
a patient in France strongly suggests 
contamination by a non-European 
strain, either during residence abroad 
or after ingestion of imported meat. 
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Letters
Letters commenting on recent articles 
as well as letters reporting cases, 
outbreaks, or original research are 
welcome. Letters commenting on ar-
ticles should contain no more than 
300 words and 5 references; they are 
more likely to be published if submitted 
within 4 weeks of the original article’s 
publication. Letters reporting cases, 
outbreaks, or original research should 
contain no more than 800 words and 
10 references. They may have 1 
Figure or Table and should not be di-
vided into sections. All letters should 
contain material not previously pub-
lished and include a word count.